US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Oryx International Growth fund (PK) (ORYYF) 銘柄情報

Oryx International Growth fund (PK) (ORYYF)

17.10

0.00

(0.00%)

終了 6月9日 5:00AM

Oryx International Growth fund (PK) (ORYYF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

17.10

( - )

買値

15.00

売値

18.44

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

17.10

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 6,937

発行済株式数

14,000,000

配当利回り

PER

12.16

1 株当たり利益 (EPS)

1.05

歳入

18.51M

純利益

14.74M

Oryx International Growth Fund Ltd is a closed ended equity mutual fund launched and managed by Harwood Capital LLP. The fund invests in the public equity markets of the United Kingdom and United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primari... Oryx International Growth Fund Ltd is a closed ended equity mutual fund launched and managed by Harwood Capital LLP. The fund invests in the public equity markets of the United Kingdom and United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in stocks of small and mid cap companies. It employs a fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the FTSE All Share Index. Oryx International Growth Fund Ltd was formed on March 2, 1995 and is domiciled in Guernsey, Channel Islands. 詳細を表示

セクター

Finance

業界

Asset Management Services

ウェブサイト

www.oryxinternationalgrowthfund.co.uk

本社

London, United Kingdom

設立

1995

Oryx International Growth fund (PK) is listed in the Finance sector of the その他OTC with ticker ORYYF. The last closing price for Oryx International Growth (PK) was US$17.10. Over the last year, Oryx International Growth (PK) shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Oryx International Growth (PK) currently has 14,000,000 shares in issue. The market capitalisation of Oryx International Growth (PK) is US$239.40 million. Oryx International Growth (PK) has a price to earnings ratio (PE ratio) of 12.16.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR

ORYYF - Frequently Asked Questions (FAQ)

What is the current Oryx International Growth fund (PK) share price?

The current share price of Oryx International Growth fund (PK) is US$ 17.10

How many Oryx International Growth fund (PK) shares are in issue?

Oryx International Growth fund (PK) has 14,000,000 shares in issue

What is the market cap of Oryx International Growth fund (PK)?

The market capitalisation of Oryx International Growth fund (PK) is USD 239.4M

What is the 1 year trading range for Oryx International Growth fund (PK) share price?

Oryx International Growth fund (PK) has traded in the range of US$ 0.00 to US$ 0.00 during the past year

What is the PE ratio of Oryx International Growth fund (PK)?

The price to earnings ratio of Oryx International Growth fund (PK) is 12.16

What is the cash to sales ratio of Oryx International Growth fund (PK)?

The cash to sales ratio of Oryx International Growth fund (PK) is 9.68

What is the registered address of Oryx International Growth fund (PK)?

The registered address for Oryx International Growth fund (PK) is Six Stratton Street, London, Greater London, W1J 8LD

What is the Oryx International Growth fund (PK) website address?

The website address for Oryx International Growth fund (PK) is www.oryxinternationalgrowthfund.co.uk

Which industry sector does Oryx International Growth fund (PK) operate in?

Oryx International Growth fund (PK) operates in the Asset Management Services sector

PurpleCritter2001

PurpleCritter2001 4分前

You were a Photonics Engnieer at Intel for 35 years?

HyGro

Actually READ FDA ECA Guidelines:

"Sponsors should finalize a study protocol before initiating the externally controlled trial, including selection of the external control arm and analytic approach, rather than selecting an external control arm after the completion of a single-arm tri

rogers711

rogers711 6分前

Achilles deFlandres

Achilles deFlandres 6分前

Elephant in the room. After the "blah blah...blah" is over the speeding wheels of the bureaucracy will make this a many months process during which any number of events could derail it. Unfortunately the next president probably won't even discuss these things.

Zardiw

Remember the USS Liberty:

Attacked by israel:

https://www.youtube.com/watch?v=OqmoiUO4UDo

Z

Zardiw

Remember the USS Liberty:

Attacked by israel:

https://www.youtube.com/watch?v=OqmoiUO4UDo

Z

Dough Theory

Dough Theory 11分前

If a person doesn't like a stock, that's fine, then move on.
Why keep posting and show your immaturity? Who are they trying to impress?

Olle15

Olle15 12分前

The stock goes down every day..
More and more.
And the 47. Rates go down every
Day .
He must do it NOW!!!
Not bla bla bla...

flipper44

flipper44 15分前

Dr. Kalinski is the sponsor, NWBO is one of the collaborators.

Dabeav

Dabeav 17分前

Are you really letting a keyboard warrior getting under your skin, come on buddy! There is nothing anybody says on this sht show forum that means 2 fks to anyone. Don’t let this hub get to you bro. This whole hub is a sht show

Kool Aid Man

Kool Aid Man 17分前

Al-Than's bloated resume'--- Prior to his current role (with Ameerex), he served as the Assistant CEO of Qatar General Group (a major Qatari insurance and investment conglomerate) from 2015 until 2020, where he honed his expertise in managing massive multi-billion-Riyal investment portfolios . Yeah

Boston-Bets

Boston-Bets 17分前

"It is being 'shorted' so *Insiders* can 'scoop up' the Cheap shares OR are you saying we could expect these shares will be given to "WamU Escrow-holders for our Assets? "

NEITHER. The theory goes that there's apparently 100's of Millions of Class-L shares that are going to be convert

BDEZ

https://x.com/PikachOTC/status/2062848269726728334

ENZC

rogers711

rogers711 18分前

The stock price after submittal says it all. Little to no one cares about this anymore in my opinion.

Loungerr

Loungerr 18分前

I do have trading shares in Ira.though.never sold in other acct.

Slojab

Slojab 21分前

We've been trading in a channel the past three months. And we traded within that channel today. I was hoping the latest news would push us past $.01.

News of returning shares to the Treasury would do it, I bet.

biosectinvestor

biosectinvestor 23分前

The flaw in your argument is a class/category error.

You are applying a tissue-agnostic biomarker framework developed for a specific new class of oncology drugs — molecularly targeted therapies — to a different new class of treatment: dendritic-cell immunotherapy.

Those

splintered sunlight

splintered sunlight 25分前

More specific.

Sure.

Quick question.

When the FDA turned down RDGL's submission in August 2025, was it an EFS IDE submission or an IDE submission?

EarningsCentral

EarningsCentral 27分前

AKATITUS

AKATITUS 29分前

Tomorrow
Should
Be
Interesting

Alley-oop

Alley-oop 29分前

Even though the stock price is not going as expected

NY1972

NY1972 31分前

Single large dose CART is not going to work. Kimmtrak is like a weekly low dose CART

Loungerr

Loungerr 32分前

I’ve always been long and never sold a share but when I said was short ya all said at least your telling the truth.My first buy was a year ago at.98.truth

Juststoppingby

Juststoppingby 33分前

Some of those 10 million shares that convert to 200+some cheers were also for some of the Coretec old management/board members. I have to look back; it's been almost two years.
When they file, we will know exactly who gets what.
If they want to uplist to NASDAQ, they aren't going to co

CatfishHunter

CatfishHunter 33分前

Be more specific, as they waisted few years at the beginning trying for DeNovo when they should have known FDA would never giveClass 2 designation to Radiogel. After that, it has always been EFS IDE. Just the earlier EFS submissions were MK doing it on his own. This current EFS IDE is with a John

Oryx International Growth (PK)

Great Northern Energy Me...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。